Annual Total Expenses
$89.04 M
+$14.30 M+19.14%
31 December 2023
Summary:
OptimizeRx annual total expenses is currently $89.04 million, with the most recent change of +$14.30 million (+19.14%) on 31 December 2023. During the last 3 years, it has risen by +$28.11 million (+46.14%). OPRX annual total expenses is now at all-time high.OPRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$22.38 M
-$179.00 K-0.79%
30 September 2024
Summary:
OptimizeRx quarterly total expenses is currently $22.38 million, with the most recent change of -$179.00 thousand (-0.79%) on 30 September 2024. Over the past year, it has dropped by -$8.01 million (-26.36%). OPRX quarterly total expenses is now -26.36% below its all-time high of $30.39 million, reached on 31 December 2023.OPRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPRX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -26.4% |
| 3 y3 years | +46.1% | +13.7% |
| 5 y5 years | +223.9% | +151.5% |
OPRX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.1% | -26.4% | +27.9% |
| 5 y | 5 years | at high | +223.9% | -26.4% | +151.5% |
| alltime | all time | at high | >+9999.0% | -26.4% | >+9999.0% |
OptimizeRx Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.38 M(-0.8%) |
| June 2024 | - | $22.56 M(-8.7%) |
| Mar 2024 | - | $24.72 M(-18.7%) |
| Dec 2023 | $89.04 M(+19.1%) | $30.39 M(+52.8%) |
| Sept 2023 | - | $19.88 M(+6.5%) |
| June 2023 | - | $18.67 M(-7.0%) |
| Mar 2023 | - | $20.07 M(-2.2%) |
| Dec 2022 | $74.74 M(+22.7%) | $20.52 M(+8.9%) |
| Sept 2022 | - | $18.84 M(+5.3%) |
| June 2022 | - | $17.89 M(+2.3%) |
| Mar 2022 | - | $17.49 M(-11.2%) |
| Dec 2021 | $60.93 M(+34.1%) | $19.69 M(+22.4%) |
| Sept 2021 | - | $16.09 M(+21.1%) |
| June 2021 | - | $13.29 M(+11.9%) |
| Mar 2021 | - | $11.87 M(-21.2%) |
| Dec 2020 | $45.45 M(+65.3%) | $15.07 M(+40.9%) |
| Sept 2020 | - | $10.70 M(+8.7%) |
| June 2020 | - | $9.84 M(-0.0%) |
| Mar 2020 | - | $9.84 M(+10.6%) |
| Dec 2019 | $27.49 M(+34.6%) | $8.90 M(+27.3%) |
| Sept 2019 | - | $6.99 M(+7.1%) |
| June 2019 | - | $6.53 M(+28.5%) |
| Mar 2019 | - | $5.08 M(-17.3%) |
| Dec 2018 | $20.42 M(+43.2%) | $6.14 M(+19.4%) |
| Sept 2018 | - | $5.15 M(+6.6%) |
| June 2018 | - | $4.83 M(+12.1%) |
| Mar 2018 | - | $4.30 M(+1.3%) |
| Dec 2017 | $14.26 M(+53.6%) | $4.25 M(+13.8%) |
| Sept 2017 | - | $3.73 M(+15.3%) |
| June 2017 | - | $3.24 M(+6.4%) |
| Mar 2017 | - | $3.04 M(+9.8%) |
| Dec 2016 | $9.28 M | $2.77 M(+36.1%) |
| Sept 2016 | - | $2.04 M(-13.6%) |
| June 2016 | - | $2.36 M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $2.12 M(-12.9%) |
| Dec 2015 | $7.82 M(+9.7%) | $2.44 M(+26.9%) |
| Sept 2015 | - | $1.92 M(+3.0%) |
| June 2015 | - | $1.86 M(+16.5%) |
| Mar 2015 | - | $1.60 M(-7.9%) |
| Dec 2014 | $7.13 M(+44.1%) | $1.74 M(-17.9%) |
| Sept 2014 | - | $2.11 M(+30.0%) |
| June 2014 | - | $1.63 M(-1.5%) |
| Mar 2014 | - | $1.65 M(+17.1%) |
| Dec 2013 | $4.95 M(+102.4%) | $1.41 M(-6.8%) |
| Sept 2013 | - | $1.51 M(+50.8%) |
| June 2013 | - | $1.00 M(+12.4%) |
| Mar 2013 | - | $893.80 K(+34.9%) |
| Dec 2012 | $2.44 M(-4.7%) | $662.80 K(+18.5%) |
| Sept 2012 | - | $559.30 K(-5.5%) |
| June 2012 | - | $591.60 K(-6.1%) |
| Mar 2012 | - | $630.30 K(-11.2%) |
| Dec 2011 | $2.57 M(+33.8%) | $709.80 K(+18.1%) |
| Sept 2011 | - | $600.80 K(-3.2%) |
| June 2011 | - | $620.70 K(-2.1%) |
| Mar 2011 | - | $634.30 K(+193.4%) |
| Dec 2010 | $1.92 M(-58.4%) | $216.20 K(-60.4%) |
| Sept 2010 | - | $545.90 K(-38.8%) |
| June 2010 | - | $892.10 K(+239.1%) |
| Mar 2010 | - | $263.10 K(-88.8%) |
| Dec 2009 | $4.61 M(+189.8%) | $2.35 M(+275.0%) |
| Sept 2009 | - | $626.00 K(+76.1%) |
| June 2009 | - | $355.50 K(-74.2%) |
| Mar 2009 | - | $1.38 M(+44.3%) |
| Dec 2008 | $1.59 M(+248.8%) | $953.50 K(+486.8%) |
| Sept 2008 | - | $162.50 K(-25.8%) |
| June 2008 | - | $218.90 K(-17.7%) |
| Mar 2008 | - | $266.10 K |
| Dec 2007 | $456.30 K | - |
FAQ
- What is OptimizeRx annual total expenses?
- What is the all time high annual total expenses for OptimizeRx?
- What is OptimizeRx quarterly total expenses?
- What is the all time high quarterly total expenses for OptimizeRx?
- What is OptimizeRx quarterly total expenses year-on-year change?
What is OptimizeRx annual total expenses?
The current annual total expenses of OPRX is $89.04 M
What is the all time high annual total expenses for OptimizeRx?
OptimizeRx all-time high annual total expenses is $89.04 M
What is OptimizeRx quarterly total expenses?
The current quarterly total expenses of OPRX is $22.38 M
What is the all time high quarterly total expenses for OptimizeRx?
OptimizeRx all-time high quarterly total expenses is $30.39 M
What is OptimizeRx quarterly total expenses year-on-year change?
Over the past year, OPRX quarterly total expenses has changed by -$8.01 M (-26.36%)